45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Grazyna Riebandt, PharmD

Clinical Pharmacy Service Director
Roswell Park Cancer Institute
Elm & Carlton St
Buffalo, NY
USA 14263

Papers:
169 - Poster Session A Oxaliplatin is a safe alternative therapeutic option for patients with recurrent gynecologic cancers following hypersensitivity reaction to carboplatin